Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Proportion of asymptomatic coronavirus disease 2019: a systematic review and meta‐analysis

J He, Y Guo, R Mao, J Zhang - Journal of medical virology, 2021 - Wiley Online Library
We aim to systematically review the characteristics of asymptomatic infection in the
coronavirus disease 2019 (COVID‐19). PubMed and EMBASE were electronically searched …

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

M Pollán, B Pérez-Gómez, R Pastor-Barriuso, J Oteo… - The Lancet, 2020 - thelancet.com
Background Spain is one of the European countries most affected by the COVID-19
pandemic. Serological surveys are a valuable tool to assess the extent of the epidemic …

[HTML][HTML] Infection fatality rate of COVID-19 inferred from seroprevalence data

JPA Ioannidis - Bulletin of the world health organization, 2021 - ncbi.nlm.nih.gov
Objective To estimate the infection fatality rate of coronavirus disease 2019 (COVID-19) from
seroprevalence data. Methods I searched PubMed and preprint servers for COVID-19 …

[HTML][HTML] A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates

G Meyerowitz-Katz, L Merone - International Journal of Infectious Diseases, 2020 - Elsevier
An important unknown during the coronavirus disease-2019 (COVID-19) pandemic has
been the infection fatality rate (IFR). This differs from the case fatality rate (CFR) as an …

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

S Uyoga, IMO Adetifa, HK Karanja, J Nyagwange… - Science, 2021 - science.org
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa is
poorly described. The first case of SARS-CoV-2 in Kenya was reported on 12 March 2020 …

Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays

A La Marca, M Capuzzo, T Paglia, L Roli… - Reproductive …, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
coronavirus disease 2019 (COVID-19) pandemic has demanded rapid upscaling of in-vitro …

Thoracic imaging tests for the diagnosis of COVID‐19

N Islam, S Ebrahimzadeh, JP Salameh… - Cochrane Database …, 2021 - cochranelibrary.com
Background The respiratory illness caused by SARS‐CoV‐2 infection continues to present
diagnostic challenges. Our 2020 edition of this review showed thoracic (chest) imaging to be …

Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies

I Montesinos, D Gruson, B Kabamba, H Dahma… - Journal of clinical …, 2020 - Elsevier
Abstract Introduction Several SARS-CoV-2 immunoassays have been developed recently.
The purpose of this study was to assess the performance of five immunoassays for the …

[HTML][HTML] Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review

D Jarrom, L Elston, J Washington… - BMJ evidence-based …, 2022 - ebm.bmj.com
Objectives We undertook a rapid systematic review with the aim of identifying evidence that
could be used to answer the following research questions:(1) What is the clinical …